Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xingqi Tanikal capsule for functional constipation
CTR20222284Phase 2Terminated
- Sponsor
- Xinjiang Uygur Pharmaceutical Co., Ltd.
- Start
- Sep 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xingqi Tanikal capsule in functional constipation (FC), sponsored by Xinjiang Uygur Pharmaceutical Co., Ltd.. Started Sep 2022; status: terminated.
02
Drugs
Xingqi Tanikal capsule
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on CTR20222284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222284.